Literature DB >> 11996238

Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome.

Steven M Fiser1, Curtis G Tribble, Stewart M Long, Aditya K Kaza, John A Kern, David R Jones, Mark K Robbins, Irving L Kron.   

Abstract

BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is the most common cause of long-term morbidity and mortality after lung transplantation. Our hypothesis was that early ischemia-reperfusion injury after lung transplantation increases the risk of BOS.
METHODS: Data on 134 patients who had lung transplantation between January 1, 1990 and January 1, 2000, was used for univariate and multivariate logistic regression analysis.
RESULTS: After lung transplantation, 115 patients (115 of 134, 86%) survived more than 3 months. In that group, 41 patients developed BOS, of which 23 had progressive disease. Univariate analysis revealed that ischemia-reperfusion injury (p = 0.017) and two or more acute rejection episodes (p = 0.032) were predictors of BOS onset, whereas ischemia-reperfusion injury (p = 0.011) and cytomegalovirus infection (p = 0.009) predicted progressive BOS. Multivariate logistic regression analysis showed that ischemia-reperfusion injury was an independent predictor for both BOS development and BOS progression. Two or more acute rejection episodes were also an independent predictor of BOS development, whereas cytomegalovirus infection was an independent predictor of progressive BOS.
CONCLUSIONS: Ischemia-reperfusion injury increases the risk of BOS after lung transplantation.

Entities:  

Mesh:

Year:  2002        PMID: 11996238     DOI: 10.1016/s0003-4975(01)03606-2

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  78 in total

1.  Adenosine signaling via the adenosine 2B receptor is involved in bronchiolitis obliterans development.

Authors:  Yunge Zhao; Damien J LaPar; John Steidle; Abbas Emaminia; Irving L Kron; Gorav Ailawadi; Joel Linden; Christine L Lau
Journal:  J Heart Lung Transplant       Date:  2010-12       Impact factor: 10.247

2.  The influence of lung ischemia-reperfusion injury on myocardium.

Authors:  Meng Shi; Jiechun Huang; Liewen Pang; Xiaotian Sun; Xianglin Chu; Rongrong Jang; Xiaolin Xu; Yiqing Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  Special issues in the management and selection of the donor for lung transplantation.

Authors:  Priyumvada M Naik; Luis F Angel
Journal:  Semin Immunopathol       Date:  2011-04-15       Impact factor: 9.623

Review 4.  Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.

Authors:  Andrew I R Scott; Linda D Sharples; Susan Stewart
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Inducible nitric oxide synthase inhibition reverses pulmonary arterial dysfunction in lung transplantation.

Authors:  Jing-Xiang Wu; Hong-Wei Zhu; Xu Chen; Jiong-Lin Wei; Xiao-Feng Zhang; Mei-Ying Xu
Journal:  Inflamm Res       Date:  2014-04-24       Impact factor: 4.575

6.  Transcript signatures of lymphocytic bronchitis in lung allograft biopsy specimens.

Authors:  Xiang Xu; Jeffrey A Golden; Gregory Dolganov; Kirk D Jones; Samantha Donnelly; Timothy Weaver; George H Caughey
Journal:  J Heart Lung Transplant       Date:  2005-08       Impact factor: 10.247

7.  Carbon monoxide-saturated preservation solution protects lung grafts from ischemia-reperfusion injury.

Authors:  Junichi Kohmoto; Atsunori Nakao; Ryujiro Sugimoto; Yinna Wang; Jianghua Zhan; Hideo Ueda; Kenneth R McCurry
Journal:  J Thorac Cardiovasc Surg       Date:  2008-07-26       Impact factor: 5.209

8.  Differential toll-like receptor activation in lung ischemia reperfusion injury.

Authors:  Patrick Phelan; Heather E Merry; Billanna Hwang; Michael S Mulligan
Journal:  J Thorac Cardiovasc Surg       Date:  2015-02-28       Impact factor: 5.209

9.  Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide.

Authors:  Stavros Garantziotis; Scott M Palmer; Laurie D Snyder; Tonya Ganous; Benny J Chen; Tie Wang; Donald N Cook; David A Schwartz
Journal:  Transplantation       Date:  2007-10-27       Impact factor: 4.939

10.  Preoperative echocardiographic-defined moderate-severe pulmonary hypertension predicts prolonged duration of mechanical ventilation following lung transplantation for patients with COPD.

Authors:  Jeremy P Wrobel; Bruce R Thompson; Gregory I Snell; Trevor J Williams
Journal:  Lung       Date:  2012-10-12       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.